Clinical Immunology & Research

Clinical Immunology & Research

Open Access
ISSN: 2639-8494
Research Article

COVID-19 and Repurposed Drugs How Much is A Human Life?.

Authors: Carvallo Hector E, Matozza Francesco, Hirsch Roberto R.

DOI: 10.33425/2639-8494.1032


Abstract

The current pandemic due to COVID 19 (SARS COV2) has revealed a disturbing reality most of the world's health systems, and the organizations that govern health policies at a global level, have not been able to meet the expectations that were set on them. On the one hand, W.H.O has shown hesitations, orders, counter-orders, delays and errors that have made it lose credibility. The terrible images of corpses piled up in the corridors of healthcare centers (from underdeveloped countries to the most powerful ones in the planet); will remain forever in our memory. The enormous financial effort made was not always well targeted, and rarely benefited the patients. The cost / benefit ratio was inverted, contributing fortunes in the final monitoring of severe cases, when logic indicates that emphasis should be placed on not reaching severe stages, and must be solved earlier. In this article, we establish a comparison between what is done and what - in our opinion - should be done.

View / Download PDF
Citation: Carvallo Hector E, Matozza Francesco, Hirsch Roberto R. COVID-19 and Repurposed Drugs How Much is A Human Life?. 2021; 5(1). DOI: 10.33425/2639-8494.1032
Editor-in-Chief
Jianxun Song
Jianxun Song
Microbial Pathogenesis & Immunology | Pennsylvania State University

View full editorial board →
Journal Metrics
Impact Factor 2.4*
Acceptance Rate 74%
Time to first decision 6-10 Days
Submission to acceptance 12-15 Days